Close Menu
Global News HQ
    What's Hot

    Wordle today: Answer, hints for June 30, 2025

    June 30, 2025

    The Trade Desk: Strong Buy On Kokai’s Transformative Impact (NASDAQ:TTD)

    June 30, 2025

    A NYC Heat Wave and 100+ Degrees In Vegas Were No Match for This Tinted Sunscreen

    June 30, 2025
    Recent Posts
    • Wordle today: Answer, hints for June 30, 2025
    • The Trade Desk: Strong Buy On Kokai’s Transformative Impact (NASDAQ:TTD)
    • A NYC Heat Wave and 100+ Degrees In Vegas Were No Match for This Tinted Sunscreen
    • H1 2025 Hacks Hit $2.1B Record, Led by North Korean Actors: Report
    • One of the World’s Largest Alcohol Companies Isn’t Giving Up on Wine
    Facebook X (Twitter) Instagram YouTube TikTok
    Trending
    • Wordle today: Answer, hints for June 30, 2025
    • The Trade Desk: Strong Buy On Kokai’s Transformative Impact (NASDAQ:TTD)
    • A NYC Heat Wave and 100+ Degrees In Vegas Were No Match for This Tinted Sunscreen
    • H1 2025 Hacks Hit $2.1B Record, Led by North Korean Actors: Report
    • One of the World’s Largest Alcohol Companies Isn’t Giving Up on Wine
    • SCOTUS Decision on Nationwide Injunctions: Trump v. Casa and Its Impact on Federal Litigation
    • What’s Worse than Lost FBA Inventory? When Amazon Finds It
    • Understanding Small Business Customer Expectations for Success
    Global News HQ
    • Technology & Gadgets
    • Travel & Tourism (Luxury)
    • Health & Wellness (Specialized)
    • Home Improvement & Remodeling
    • Luxury Goods & Services
    • Home
    • Finance & Investment
    • Insurance
    • Legal
    • Real Estate
    • More
      • Cryptocurrency & Blockchain
      • E-commerce & Retail
      • Business & Entrepreneurship
      • Automotive (Car Deals & Maintenance)
    Global News HQ
    Home - Health & Wellness (Specialized) - Diagnosed With Metastatic Castration-Resistant Prostate Cancer: What’s Next?
    Health & Wellness (Specialized)

    Diagnosed With Metastatic Castration-Resistant Prostate Cancer: What’s Next?

    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
    Diagnosed With Metastatic Castration-Resistant Prostate Cancer: What’s Next?
    Share
    Facebook Twitter LinkedIn Pinterest Email


    The term metastatic castration-resistant prostate cancer (mCRPC) refers to a cancer that has spread (metastasized) beyond your prostate gland and for which hormone therapy is no longer effective in stopping or slowing the progression of the cancer. In the past, this was known as hormone-refractory and androgen-independent prostate cancer, but these terms are rarely used now.

    This type of prostate cancer can be very hard to treat, even when doctors catch it early. “This cancer escapes control,” says Michael S. Cookson, MD, a urologic oncologist, as well as a professor of and the chair of urology at the University of Oklahoma College of Medicine in Oklahoma City. “[MCRPC is] like a car that keeps moving, even though you’re pushing on the brakes in the form of hormone therapy.”

    It’s common for hormone therapy, known as androgen deprivation therapy (ADT) or “chemical castration,” to stop working after a few years. The goal of the therapy is to block testosterone from stimulating the cancer to keep growing. The term “castration resistant” refers to a cancer that is no longer responding to ADT.

    According to some research, mCRPC accounts for about 1 to 2 percent of all prostate cancer cases worldwide.

     But it’s hard to pin down exact numbers, partly because newer, more sensitive imaging technologies are now able to find smaller cancer cells beyond the prostate gland that couldn’t be found before. So the same cancer that would have been considered nonmetastatic before is considered metastatic today, explains Scott T. Tagawa, MD, a medical oncologist at NewYork-Presbyterian Hospital and professor of urology at Weill Cornell Medicine in New York City.

    “Our scans are getting better,” says Dr. Tagawa. “When we just had X-rays, we missed small things. Then we got MRIs and CT scans, and we still missed some things. But now that we have more specific PET scans, we can see things we couldn’t see before.” And finding cancer sooner means treating it sooner.



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Previous ArticleBeyond sells major stake in Zulily for $5 million
    Next Article European military powers work on 5-10 year plan to replace US in Nato

    Related Posts

    A NYC Heat Wave and 100+ Degrees In Vegas Were No Match for This Tinted Sunscreen

    June 30, 2025

    Why This Spice Expert Wants You To Add Sumac To Your Spice Rack

    June 29, 2025

    8 Healing Practices To Do The Next Time You’re Struggling

    June 29, 2025

    Strawberries Support Cognition & Heart Health, Research Shows

    June 28, 2025
    Leave A Reply Cancel Reply

    ads
    Don't Miss
    Technology & Gadgets
    3 Mins Read

    Wordle today: Answer, hints for June 30, 2025

    Oh hey there! If you’re here, it must be time for Wordle. As always, we’re…

    The Trade Desk: Strong Buy On Kokai’s Transformative Impact (NASDAQ:TTD)

    June 30, 2025

    A NYC Heat Wave and 100+ Degrees In Vegas Were No Match for This Tinted Sunscreen

    June 30, 2025

    H1 2025 Hacks Hit $2.1B Record, Led by North Korean Actors: Report

    June 30, 2025
    Top
    Technology & Gadgets
    3 Mins Read

    Wordle today: Answer, hints for June 30, 2025

    Oh hey there! If you’re here, it must be time for Wordle. As always, we’re…

    The Trade Desk: Strong Buy On Kokai’s Transformative Impact (NASDAQ:TTD)

    June 30, 2025

    A NYC Heat Wave and 100+ Degrees In Vegas Were No Match for This Tinted Sunscreen

    June 30, 2025
    Our Picks
    Technology & Gadgets
    3 Mins Read

    Wordle today: Answer, hints for June 30, 2025

    Oh hey there! If you’re here, it must be time for Wordle. As always, we’re…

    Finance & Investment
    2 Mins Read

    The Trade Desk: Strong Buy On Kokai’s Transformative Impact (NASDAQ:TTD)

    This article was written byFollowMoretus Research delivers state-of-the-art, buy-side quality equity research for serious investors…

    Pages
    • About Us
    • Contact Us
    • Disclaimer
    • Homepage
    • Privacy Policy
    Facebook X (Twitter) Instagram YouTube TikTok
    • Home
    © 2025 Global News HQ .

    Type above and press Enter to search. Press Esc to cancel.

    Go to mobile version